Updated:
Flagship Pioneering
Flagship Pioneering is an exempt reporting adviser in Cambridge, MA. It advises on investment strategies. Flagship Pioneering is based in the United States.
Flagship Pioneering
Flagship Pioneering is an exempt reporting adviser in Cambridge, MA. It advises on investment strategies. Flagship Pioneering is based in the United States.
General information
Firm type
Private Equity
Year founded
2000
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
Cambridge, MA, United States
Principals
Hari Pujar
Flagship Operating Partner
Adrian Rawcliffe
CEO-Partner
Rahul Kakkar
CEO-Partner
Sector focus
Frequently asked questions
How does Flagship Pioneering originate its companies?
Flagship generates intellectual property and launches startups entirely in-house. Its internal scientific team pursues speculative 'what-if' hypotheses, funds the early research, files patents, and then incorporates a company around the resulting technology. It recruits external CEOs only after the startup has a defined platform and initial capital.
Does Flagship invest in external startups, or only its own?
Flagship focuses overwhelmingly on companies it conceives and builds internally. It does not operate as a traditional venture capital firm that invests in third-party startups seeking capital. Its capital is deployed into its own incubated companies from seed through late stage.
What is the relationship between Flagship Pioneering and Moderna?
Moderna was conceived, capitalized, and incorporated inside Flagship Pioneering. Flagship's internal exploratory unit developed the mRNA platform concept, filed the foundational patent estate, and launched Moderna as a Flagship portfolio company before recruiting external leadership.
What types of platforms does Flagship build?
Flagship builds bioplatforms — broad biological engineering systems that can generate multiple products across therapeutics, agriculture, and industrial biotechnology. Its companies have applied these platforms to areas including mRNA, gene editing, microbiome science, protein engineering, and cell therapy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: